# Insomnia Prevalence and Treatment Impact on Systemic Hypertension

> **NCT05414864** · PHASE4 · TERMINATED · sponsor: **University of Sao Paulo** · enrollment: 5 (actual)

## Conditions studied

- Insomnia
- Hypertension

## Interventions

- **DRUG:** Ramelteon (RozeremR)
- **BEHAVIORAL:** sleep hygiene

## Key facts

- **NCT ID:** NCT05414864
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-01
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-09-30
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Takeda suspended financial support. The first phase (observational study) is ongoing.
- **Last updated:** 2022-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414864, "Insomnia Prevalence and Treatment Impact on Systemic Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05414864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*